151 related articles for article (PubMed ID: 30400036)
41. In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469.
Urban C; Hamacher A; Partke HJ; Roden M; Schinner S; Christiansen E; Due-Hansen ME; Ulven T; Gohlke H; Kassack MU
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1021-30. PubMed ID: 23861168
[TBL] [Abstract][Full Text] [Related]
42. Identification of berberine as a novel agonist of fatty acid receptor GPR40.
Rayasam GV; Tulasi VK; Sundaram S; Singh W; Kant R; Davis JA; Saini KS; Ray A
Phytother Res; 2010 Aug; 24(8):1260-3. PubMed ID: 20658575
[TBL] [Abstract][Full Text] [Related]
43. Evidence for the involvement of GPR40 and NADPH oxidase in palmitic acid-induced superoxide production and insulin secretion.
Graciano MF; Valle MM; Curi R; Carpinelli AR
Islets; 2013; 5(4):139-48. PubMed ID: 23817296
[TBL] [Abstract][Full Text] [Related]
44. Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion.
Cripps MJ; Bagnati M; Jones TA; Ogunkolade BW; Sayers SR; Caton PW; Hanna K; Billacura MP; Fair K; Nelson C; Lowe R; Hitman GA; Berry MD; Turner MD
Biochem Pharmacol; 2020 Jan; 171():113685. PubMed ID: 31678493
[TBL] [Abstract][Full Text] [Related]
45. Coordination of GPR40 and Ketogenesis Signaling by Medium Chain Fatty Acids Regulates Beta Cell Function.
Pujol JB; Christinat N; Ratinaud Y; Savoia C; Mitchell SE; Dioum EHM
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29649104
[TBL] [Abstract][Full Text] [Related]
46. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
47. A novel GPR120-selective agonist promotes insulin secretion and improves chronic inflammation.
Yang L; Lei XT; Huang Q; Wang T; Sun HB; Wang HY
Life Sci; 2021 Mar; 269():119029. PubMed ID: 33450256
[TBL] [Abstract][Full Text] [Related]
48. Trans-11 vaccenic acid improves insulin secretion in models of type 2 diabetes in vivo and in vitro.
Wang X; Gupta J; Kerslake M; Rayat G; Proctor SD; Chan CB
Mol Nutr Food Res; 2016 Apr; 60(4):846-57. PubMed ID: 27061233
[TBL] [Abstract][Full Text] [Related]
49. Cysteinyl leukotriene receptor 1 regulates glucose-stimulated insulin secretion (GSIS).
Guo R; Jiang J; Jing Z; Chen Y; Shi Z; Deng B
Cell Signal; 2018 Jun; 46():129-134. PubMed ID: 29412178
[TBL] [Abstract][Full Text] [Related]
50. Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold.
Li H; Huang Q; Chen C; Xu B; Wang HY; Long YQ
J Med Chem; 2017 Apr; 60(7):2697-2717. PubMed ID: 28277660
[TBL] [Abstract][Full Text] [Related]
51. Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
Zhao T; Wang J; He A; Wang S; Chen Y; Lu J; Lv J; Li S; Wang J; Qian M; Li H; Shen X
Metabolism; 2021 Jun; 119():154771. PubMed ID: 33831422
[TBL] [Abstract][Full Text] [Related]
52. GPR40-Mediated G
Rives ML; Rady B; Swanson N; Zhao S; Qi J; Arnoult E; Bakaj I; Mancini A; Breton B; Lee SP; Player MR; Pocai A
Mol Pharmacol; 2018 Jun; 93(6):581-591. PubMed ID: 29572336
[TBL] [Abstract][Full Text] [Related]
53. Tetramethylpyrazine prevents diabetes by activating PI3K/Akt/GLUT-4 signalling in animal model of type-2 diabetes.
Rai U; Kosuru R; Prakash S; Singh SP; Birla H; Tiwari V; Singh S
Life Sci; 2019 Nov; 236():116836. PubMed ID: 31493479
[TBL] [Abstract][Full Text] [Related]
54. DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.
Sun P; Wang T; Zhou Y; Liu H; Jiang H; Zhu W; Wang H
PLoS One; 2013; 8(6):e66744. PubMed ID: 23776696
[TBL] [Abstract][Full Text] [Related]
55. Octanoic acid potentiates glucose-stimulated insulin secretion and expression of glucokinase through the olfactory receptor in pancreatic β-cells.
Leem J; Shim HM; Cho H; Park JH
Biochem Biophys Res Commun; 2018 Sep; 503(1):278-284. PubMed ID: 29885841
[TBL] [Abstract][Full Text] [Related]
56. SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways.
Zhou TT; Quan LL; Chen LP; Du T; Sun KX; Zhang JC; Yu L; Li Y; Wan P; Chen LL; Jiang BH; Hu LH; Chen J; Shen X
Cell Death Dis; 2016 May; 7(5):e2216. PubMed ID: 27148689
[TBL] [Abstract][Full Text] [Related]
57. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
58. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
[TBL] [Abstract][Full Text] [Related]
59. Chronic treatment with novel GPR40 agonists improve whole-body glucose metabolism based on the glucose-dependent insulin secretion.
Tanaka H; Yoshida S; Oshima H; Minoura H; Negoro K; Yamazaki T; Sakuda S; Iwasaki F; Matsui T; Shibasaki M
J Pharmacol Exp Ther; 2013 Sep; 346(3):443-52. PubMed ID: 23853170
[TBL] [Abstract][Full Text] [Related]
60. Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats.
Koyama R; Ookawara M; Watanabe M; Moritoh Y
Mol Pharmacol; 2021 Apr; 99(4):286-293. PubMed ID: 33547250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
